Nanofilm Technologies (MZH) Q3 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 TU earnings summary
28 Oct, 2026Executive summary
3Q2026 revenue rose 2% YoY to S$74m; 9M2026 revenue rose 4% to S$187m, with IEBU and NFBU growth partly offset by softer AMBU revenue.
3Q gross profit and EBITDA margins each expanded 5 percentage points YoY, to 45% and 32%, respectively.
Financial highlights
3Q2026 revenue was S$74m, up 2% YoY; 9M2026 revenue was S$187m, up 4% YoY.
AMBU contributed 82% of 9M2026 revenue.
Outlook and guidance
AM-Consumer’s functional coating project reached full capacity; new-substrate engineering targets 2027 mass production, with the segment expected to return to YoY growth in 2027.
AM-Industrial expects growth across regions in General Industry, Semiconductor, PCB and light-metal micro-tools, Medical, Life Science, and Printing & Imaging.
Rising AI demand may support further IEBU equipment orders; development targets AI-driven industries and next-generation manufacturing capabilities.
NFBU is positioned to pursue smartphone and smartwatch opportunities using established capabilities.
Sydrogen is diversifying into titanium electrode coatings, with industrial-customer deliveries scheduled to begin in 4Q2026; its first Singapore hydrogen pipeline-to-power system is being commissioned.
Latest events from Nanofilm Technologies
- Capacity investments and segment momentum underpin growth plans amid supply-chain disruption.MZH
Q4 2021 TU - Record FY2021 results and expanded capacity set the stage for FY2022 growth.MZH
H2 2021 - Revenue grew 24.2%, while startup and NPI costs pressured profit and margins.MZH
H1 2021 - 2H recovery lifted earnings and margins, underpinning conditional FY2024 growth expectations.MZH
H2 2023 - Headwinds cut FY2022 results, while expansion and the 2025 targets remained on track.MZH
H2 2022 - Revenue fell 34.4% as consumer weakness drove a H1 loss; 2H revenue is expected higher.MZH
H1 2023 - Revenue rose 29.6% as PATMI returned to profit and adjusted EBITDA grew 46.1%.MZH
H1 2025 - Revenue grew 13%, adjusted EBITDA rose 61.4%, and FY2024 growth is expected.MZH
H1 2024 - Revenue rose 15% and adjusted EBITDA 31%, supported by growth and global expansion.MZH
H2 2024